David A. Siegel Dyadic International Inc Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Shares
3 transactions
Others Institutions Holding DYAI
# of Institutions
33Shares Held
4.52MCall Options Held
1.2KPut Options Held
0-
Bandera Partners LLC New York, NY1.57MShares$2.27 Million1.04% of portfolio
-
Chapin Davis, Inc. Baltimore, MD826KShares$1.2 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$1.17 Million0.0% of portfolio
-
Northeast Financial Consultants Inc Westport, CT250KShares$362,5000.02% of portfolio
-
Black Rock Inc. New York, NY247KShares$358,8190.0% of portfolio
About DYADIC INTERNATIONAL INC
- Ticker DYAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,423,100
- Market Cap $41.2M
- Description
- Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...